Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells

The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway has emerged as a cancer therapeutic target. However, clinical trials have proven that most human cancers are resistant to TRAIL. We show that exposure to recombinant TRAIL resulted in the accumulation of ubiquitinated protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Potu, Harish, Kandarpa, Malathi, Peterson, Luke F., Donato, Nicholas J., Talpaz, Moshe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791380/
https://www.ncbi.nlm.nih.gov/pubmed/31645897
http://dx.doi.org/10.18632/oncotarget.27196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791380/
https://www.ncbi.nlm.nih.gov/pubmed/31645897
http://dx.doi.org/10.18632/oncotarget.27196

Ejemplares similares